Synopsis Diabetes mellitus is known to be associated with an increased risk of cardiovascular events. Aspirin use reduces the risk of occlusive vascular events but in-turn increases the risk of bleeding. Thus, the present study evaluates the effect of aspirin in the prevention of vascular events in patients with T2DM. This week’s “MED FACT” discusses a clinical study from The New England Journal of Medicine, “Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus ”.
Authors: L Bowman, M Mafham, K Wallendszus et al. Key Takeaways: Adding aspirin medication to the treatment regimen of T2DM prevented serious vascular events with no evident cardiovascular disease. Objective: To evaluate the effect of aspirin in preventing vascular diseases in T2DM Study Type: Randomized Control Trial Participants: 15,480 What was the need for this study? It is well established that…
